Research from Tech in Asia, Tech in Asia

Tech in Asia

Research from Tech in Asia

Tech in Asia (YC W15) is the largest English-language technology media company that focuses on Asia. From the latest news to the hottest trends and the boldest startups to the strongest titans, we cover everything tech in the region. Our goal is to build and serve Asia’s tech and startup community.

News from Tech in Asia

Private Capital Markets

SCG Cell Therapy / Private Capital Markets

<ul>
<li>Singapore-based <a href="http://www.scgcell.com/" target="_blank" rel="noopener">SCG Cell Therapy</a>, a biotech firm, has recently raised US$8.1 million at a valuation over US$210 million, according to VentureCap Insights, which tracks regulatory filings in Singapore.</li>
<li>The lead backer of the fundraise – which was marked as a series C1 round – was Hong Kong-based Smartech Investment Holdings, pouring about US$3.4 million into SCG Cell Therapy.</li>
<li>The investment firm has also backed other Singaporean biotech firms such as <a href="http://www.biocheetah.com/" target="_blank" rel="noopener">Biocheetah</a> and <a href="http://liontcr.com/" target="_blank" rel="noopener">Lion TCR</a>.</li>
</ul>


Singapore-based SCG Cell Therapy, a biotech firm, has recently raised US$8.1 million at a valuation over US$210 million, according to VentureCap Insights, which tracks regulatory filings in Singapore.
The lead backer of the fundraise – which was marked as a series C1 round – was Hong Kong-based Smartech Investment Holdings, pouring about US$3.4 million into SCG Cell Therapy.
The investment firm has also backed other Singaporean biotech firms such as Biocheetah and Lion TCR.


SG Biotech Firm Secures $8.1m at $210m Valuation

Singapore

SCG CELL THERAPY is an ACRA-registered entity that has been operating for 5 years 6 months in Singapore since its incorporation in 2017. Officially, SCG CELL THERAPY PTE. LTD. is registered as Private Limited Company and primarily operates in the sector of "RESEARCH AND EXPERIMENTAL DEVELOPMENT ON MEDICAL SCIENCE".

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

SCG Cell Therapy (739SCG SP)

SG Biotech Firm Secures $8.1m at $210m Valuation

Singapore-based SCG Cell Therapy, a biotech firm, has recently raised US$8.1 million at a valuation over US$210 million, according to VentureCap...

Tech in Asia

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)